Clover Health Investments (CLOV) Q1 Revenue Tops Consensus

Clover Health Investments (NASDAQ: CLOV) reported revenue for the first quarter of $874.4 million versus the consensus estimate of $787.4 million.

GUIDANCE:

Clover Health Investments sees FY2022 revenue of $3-3.4 billion, versus the consensus of $3.24 billion.

• Total revenues are expected to be in the range of $3.0 billion to $3.4 billion. This includes projected Insurance revenue of $1.0 billion to $1.1 billion and Non-Insurance revenue of $2.0 billion to $2.3 billion.
• Insurance membership is expected to average 84,000 - 85,000, a growth rate of 26% - 27% as compared to the 2021 average. For the Non-Insurance program, the Company expects the average number of aligned beneficiaries to be 160,000 - 165,000, compared to an average of 62,125 in 2021.
• Insurance MCR is expected to be in the range of 95% - 99%. This improvement versus 2021 is expected to be driven by a combination of expected operational efficiencies, increased risk scores, and slightly lower COVID-19 costs. Non-Insurance MCR is also expected to improve versus 2021 levels. Any significant developments related to COVID-19 and/or historical utilization trends could impact these expectations.
• Adjusted Operating Expenses (Non-GAAP)(1) are expected to be between $330 million and $345 million.
• Adjusted Operating Expenses as a Percentage of Revenue (Non-GAAP)(1) is expected to be 10% - 12% compared to 18% in 2021.(1) Reconciliations of projected Adjusted Operating Expenses (Non-GAAP) to projected Salaries and Benefits Plus General and Administrative Expenses and of projected Adjusted Operating Expenses as a Percentage of Revenue (Non-GAAP) to projected Salaries and Benefits Plus General and Administrative Expenses as a Percentage of Revenue, the most directly comparable GAAP measures, are not provided because stock-based compensation expense, which is excluded from Adjusted Operating Expenses (Non-GAAP), cannot be reasonably calculated or predicted at this time without unreasonable efforts. Additional information about the Company's non-GAAP financial measures can be found under the caption "About Non-GAAP Financial Measures" below and in Appendix A.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Cracker Barrel (CBRL) Tops Q3 EPS by 71c
• Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance